
Longevity for Investors with Dr. Greg Bailey and Jess Larsen What This Longevity Investor Knows That You Don't | Karl Pfleger, Founder of AgingBiotech.info, Co-Hosted with Dr. Greg Bailey, Chairman of Juvenescence
Jul 5, 2024
Karl Pfleger, founder of AgingBiotech.info and a former Google researcher, dives deep into the rapidly evolving longevity biotech landscape. He discusses the lucrative opportunities in aging-related investments, highlighting how targeting aging could revolutionize health care. Pfleger stresses the importance of understanding mechanisms of action and shares his investment strategies. He also emphasizes the promise of senolytics, or senescent cell clearance, as a leading frontier. For aspiring investors, he recommends diving into conferences and varied resources for informed decisions.
AI Snips
Chapters
Books
Transcript
Episode notes
Aging Is Modifiable, Not An Unchangeable Clock
- Aging is a malleable biological process that can be slowed or reversed.
- Treating underlying aging mechanisms could prevent many major chronic diseases before they appear.
Learn By Listening And Using Structured Resources
- Use audio books, podcasts, and conference videos to learn while you work or commute.
- Use agingbiotech.info as a structured hub for books, videos, podcasts, and company lists.
Match Your Time Commitment To Your Investment Route
- Decide how much time you will commit: fund-level, mixed, or direct company diligence.
- If you lack time, invest via reputable funds or experienced groups and vet their diligence.






